David W. Osborne's most recent trade in Arcutis Biotherapeutics Inc was a trade of 690 Common Stock done at an average price of $15.3 . Disclosure was reported to the exchange on March 6, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 15.26 per share. | 06 Mar 2023 | 690 | 268,854 (0%) | 0% | 15.3 | 10,532 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 39,500 | 39,500 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 14,900 | 269,544 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 28 Feb 2023 | 1,198 | 254,659 (0%) | 0% | 15.8 | 18,951 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 16.17 per share. | 28 Feb 2023 | 792 | 255,857 (0%) | 0% | 16.2 | 12,804 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 16.53 per share. | 28 Feb 2023 | 15 | 254,644 (0%) | 0% | 16.5 | 248 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 25.41 per share. | 08 Jul 2022 | 2,197 | 256,649 (0%) | 0% | 25.4 | 55,835 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 20.42 per share. | 21 Apr 2022 | 2,197 | 257,229 (0%) | 0% | 20.4 | 44,872 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 35,300 | 35,300 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 13,300 | 260,282 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 16.86 per share. | 03 Mar 2022 | 828 | 259,454 (0%) | 0% | 16.9 | 13,959 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 16.43 per share. | 03 Mar 2022 | 28 | 259,426 (0%) | 0% | 16.4 | 460 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 01 Mar 2022 | 775 | 246,982 (0%) | 0% | 17.8 | 13,758 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 28,800 | 28,800 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 9,500 | 246,753 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 34.57 per share. | 01 Mar 2021 | 780 | 237,253 (0%) | 0% | 34.6 | 26,968 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 14 Dec 2020 | 15,000 | 250,533 (0%) | 0% | 30 | 450,000 | Common Stock |
| Arcutis Biotherapeutics Inc | David W. Osborne | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 29 Sep 2020 | 15,000 | 264,279 (0%) | 0% | 30 | 450,000 | Common Stock |